Target Price Playground
BIO.B
$389.98
Swing & Horizon Engine
Need pre-expiry P&L (+3d / +5d), multi-leg ratios, or hedged overlays on BIO.B? Launch with your exact active legs & +12.0% target.
โก Quant Efficiency Alert: Bull Call Spread Delivers
+213.6% ROI
vs
+143.7% ROI
on Long Call at $436.78 Target
Bull Call Spread cuts entry cost by 25% ($1,435 vs $1,920), lowers breakeven to $404.35 (+3.7%), and slashes daily theta burn from $18.90/d to $6.22/d.
Forward Projection
If price hits $437 by Jan 15
Multi-Option Simulator
Pre-expiry +3d/+5d & Overlays
Options Architect
Multi-leg solver & Greeks
1x1x1 Structure
Reverse Time-Diagonal + Call
๐ Strategy
Long Stock
Long Call
Long Put
Bull Call Spread
Bear Put Spread
Bear Call Credit Spread
Bull Put Credit Spread
Covered Call
Protective Put
Cash-Secured Put
Diagonal Put Spread
Long Straddle
Bullish. Unlimited upside, capped loss = premium paid.
๐ฏ Target
1-Click Institutional Target Anchors:
54d from today
โ๏ธ Legs
LONG CALL ยท $390 ยท Jan '27
Qty 1 ยท Premium $19.2 ยท ฮ 0.55
P&L at Expiry
Stock (100 sh)
Long Call
Now
Target
๐ก Stock vs Options at Target
If BIO.B hits $437 by Jan 15: the long call returns +$2,758 (143.7%) on $1,920 risked, vs +$4,680 (12.0%) for 100 shares on $38,998. Options give 12.0ร capital efficiency.
๐ Expiry & Gamma Wall Alignment
Options expire Jan 15, 2027 (54 days out). P&L shown is the value at expiry if BIO.B is at $437.
๐ Projected Return
P&L if BIO.B hits $437 by Jan 15
+$2,758
+143.7% on $1,920 risked
Max Profit
Unlimited
Unlimited upside
Max Loss
โ$1,920
Premium paid
Break-even
$409.20
+4.93% from spot
Prob. of Profit at Expiry (PoP)
33.8%
Above breakeven ($409.20)
ยท Touch Target: 30%
30-Day Theta Burn (If Flat)
โ$567
29.5% of entry cost ยท Daily ฮ: $-18.9/day
Net ฮ / ฮ / V
54.58 / -18.9 / 59.45
per spread, per $1 move / day / vol pt
๐ P&L Scenarios โ what happens at different prices and dates
| BIO.B Price | Today | +3d (Nov 25) | +7d (Nov 29) | Dec 10 | Dec 28 | Jan 15 (exp) |
|---|---|---|---|---|---|---|
| $312 (-20%) | -$1,873 | -$1,881 | -$1,890 | -$1,909 | -$1,920 | -$1,920 |
| $331 (-15%) | -$1,751 | -$1,771 | -$1,795 | -$1,855 | -$1,914 | -$1,920 |
| $351 (-10%) | -$1,457 | -$1,492 | -$1,540 | -$1,668 | -$1,856 | -$1,920 |
| $370 (-5%) | -$894 | -$944 | -$1,012 | -$1,211 | -$1,581 | -$1,920 |
| $382 (-2%) | -$399 | -$454 | -$531 | -$757 | -$1,205 | -$1,920 |
| $390 (0%) โ spot | -$0 | -$57 | -$136 | -$371 | -$842 | -$1,920 |
| $398 (+2%) | +$452 | +$394 | +$315 | +$81 | -$386 | -$1,142 |
| $409 (+5%) | +$1,224 | +$1,169 | +$1,093 | +$872 | +$454 | +$28 |
| $429 (+10%) | +$2,724 | +$2,677 | +$2,614 | +$2,437 | +$2,151 | +$1,978 |
| $437 (+12%) โ target | +$3,383 | +$3,341 | +$3,284 | +$3,127 | +$2,891 | +$2,758 |
| $448 (+15%) | +$4,421 | +$4,384 | +$4,336 | +$4,208 | +$4,031 | +$3,928 |
| $468 (+20%) | +$6,241 | +$6,214 | +$6,178 | +$6,087 | +$5,967 | +$5,878 |
Uses BIO.B's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.